New Telmi Tablet 40 mg (Telmisartan)

Adult dose

For essential hypertension, Telmisartan should be taken orally once a day at a dose of 40 mg with water, and it may be taken regardless of meals. Depending on the patient, 20 mg once a day may also be effective, and if necessary, it can be increased to 80 mg once a day. The maximum blood pressure-lowering effect occurs 4 to 8 weeks after starting treatment. For decreasing the risk of cardiovascular disease, 80 mg should be taken orally once a day with water.

This medication can cause serious harm to the fetus and newborn if taken during pregnancy, so use must be discontinued immediately if pregnancy is confirmed. It should not be used in individuals with allergic reactions to this medicine, pregnant or breastfeeding women, patients with severe liver impairment, patients with certain hereditary diseases, and patients with severe kidney impairment. Elderly patients, those with high potassium levels in the blood, those with weak liver function, patients with heart valve disease, and patients with gastrointestinal diseases should take this medication with caution. Various side effects such as headache, dizziness, cough, dyspepsia, skin rash, myalgia, and kidney dysfunction may occur during treatment, so if any abnormal symptoms appear, consult a doctor immediately. If symptoms of angioedema (swelling of the face, lips, tongue, etc.) appear, discontinue use immediately and inform healthcare professionals. This medication may affect kidney function, so kidney function and electrolyte levels in the blood should be monitored regularly, and caution should be taken for hypotension due to excessive blood pressure lowering. It is advisable to discontinue this medicine 24 hours before surgery. Interactions may occur when taken with other antihypertensives or certain medications, so all medication information should be informed to a doctor or pharmacist. Pregnant or breastfeeding women should avoid taking this medication, and if it must be taken, breastfeeding should be discontinued. It is recommended not to use this medication in children under 18 years of age as safety and efficacy have not been established. In case of overdose, symptoms such as hypotension, dizziness, or acute renal failure may occur, and immediate medical attention should be sought. This medication should be stored out of the reach of children and kept sealed until taken.

Serious side effects

Hives, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, pallor, severe allergic reactions, severe rash with fever, blisters, skin peeling, pain in mucous membranes of mouth/eyes, severe skin adverse reactions, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities with cough and fever, breathing problems, yellowing of skin or eyes (jaundice), generalized extreme drowsiness, liver abnormalities (jaundice), sudden

Mild side effects

• Upper respiratory tract infection
• pharyngitis
• sinusitis
• urinary tract infection
• cystitis
• anemia
• thrombocytopenia
• eosinophilia
• hypersensitivity
• hyperkalemia

This medicine should be stored in a tightly closed container to protect it from air and moisture. The storage temperature should be maintained between 1 degree and 30 degrees Celsius.

Appearance

White oblong tablet

Package unit

30 tablets/bottle, 30 tablets/box [10 tablets/Alu-Alu × 3]